Home / Inspections / 1118385

FDA Inspection 1118385 — Aurobindo Pharma Limited

Aurobindo Pharma Limited — FEI 3004446312

The FDA completed an inspection of Aurobindo Pharma Limited on February 21, 2020 in Medchal. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 21, 2020
Fiscal Year
2020
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Medchal (India)

Facility

Other inspections at this facility

  • 1286862 (OAI Fri Sep 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1241780 (VAI Thu Mar 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1046218 (VAI Fri Mar 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 847151 (NAI Fri Aug 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 793023 (VAI Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources